November 5, 2025 — Leads & Copy —
Establishment Labs Holdings Inc. (NASDAQ: ESTA) reported its third-quarter financial results, with worldwide revenue reaching $53.8 million, a 33.8% increase year-over-year, including $11.9 million in U.S. Motiva sales. The company expects 2025 revenue to exceed $210 million, surpassing previous guidance.
Third-quarter gross margin was 70.1%, up from 63.9% in the previous year. The loss from operations was $4.0 million, an improvement from $13.1 million year-over-year, while adjusted EBITDA was positive at $1.2 million compared to a $7.0 million loss in the prior year.
Establishment Labs CEO Peter Caldini highlighted the company’s focus on reaching positive cash flow next year and noted impressive U.S. growth despite market seasonality. The company anticipates capturing about 20% of the U.S. breast augmentation market by the end of 2025 and exceeding previous U.S. Motiva sales guidance.
Contact: Investor Relations, establishmentlabs.com
Source: Establishment Labs Holdings Inc.
